NACDS to 118th Congress: Now, let’s get PBM reform doneNACDS President Steve Anderson said there remains an urgent need for the current 118th Congress to reform the tactics of market-dominant pharmaceutical middlemen. Fare, CVS Pharmacy partner for Teal Pumpkin ProjectFor the third year, CVS Pharmacy is offering more than 60 allergy-friendly treats in stores and online. Hikma celebrates 40 years of Hatch-Waxman drug savings The Drug Price Competition and Patent Term Restoration Act of 1984 established the modern system for regulating generic drugs in the United States. NACDS urges FDA, HHS to preserve medication access as supply chain pursues DSCSA compliance NACDS is urging prompt action to “provide an exemption for dispensers until all trading partners can provide the required interoperable, electronic, package level data to downstream dispensers.” AAM taps John Murphy as president and CEO Murphy most recently served as the chief policy officer at the Biotechnology Innovation Organization. AAM to Congress: Pass key bills considered by the Senate HELP Committee AAM commended the slated mark up by the Senate Health, Education, Labor and Pensions Committee of two pieces of legislation. AAM: Generic medicines increase patient access more than government negotiated price controls AAM is urging Congress and regulators to stop patent abuses and streamline approvals. Biosimilars Council urges House to pass patent thicket legislation S. 150 passed the Senate and was placed on the House of Representatives' suspension calendar. AAM, Biosimilars Council releases statement on statement on Senate Judiciary Markup of PREVAIL and PERA The Association for Accessible Medicines and its Biosimilars Council oppose passage of the PREVAIL Act and the PERA Act. Former FDA commissioner Scott Gottlieb will keynote AAM's annual meeting Scott Gottlieb also will moderate the CEOs Unplugged session, where healthcare executives will share their candid insights and industry perspectives. First Previous 2 3 4 5 6 Next Last
